On April 5, 2023, the stockholders of Sio Gene Therapies, Inc. voted to liquidate and dissolve the company.

The activities necessity to complete the liquidation are being conducted by former employees of the company now engaged as consultants, working with various outside vendors, including attorneys and tax accountants.

The company expects to pay at least one liquidating dividend to its stockholders, however, the amount and timing of the dividend is still undetermined.